FIELD: medicine.
SUBSTANCE: invention concerns to medicine, namely experimental pharmacology. The invention purpose is examination of antiphlogistic (antiinflammatory) activity of a synthetic agent for creation of a new antiinflammatory medicinal substance. For this purpose a model of acute inflammatory edema is created experimentally. Then the agent received by covalent imposing of the rests of acetylsalicylic acid to betacyclodextrins is administered to a laboratory animal. Introduction of the given agent provides reliably significant inflammation reduction.
EFFECT: provision of reliably significant reduction of inflammation.
1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENTS WITH ANTI-INFLAMMATORY AND ANTIOXIDANT ACTIVITY | 2014 |
|
RU2578473C2 |
| ANTI-INFLAMMATORY AND ANALGESIC AGENT OF 1,2-DIHYDRO-1H-2-OXOCINCHONINIC ACID ISOPROPYLAMIDE | 2012 |
|
RU2545056C2 |
| AGENT POSSESSING ANTI-INFLAMMATORY AND REGENERATIVE ACTIVITY | 2018 |
|
RU2701164C1 |
| ANTI-INFLAMMATORY AGENT | 2000 |
|
RU2189828C2 |
| USE OF 3-AMINO-4-(5-METHYL-2-FURYL)-5,6,7,8-TETRAHYDROTHIENO[2,3-b]QUINOLIN-2-yl](PHENYL)METHANONE AS ANTI-INFLAMMATORY AGENT | 2023 |
|
RU2812570C1 |
| ANTI-INFLAMMATORY AGENT | 2002 |
|
RU2210380C1 |
| ANTI-INFLAMMATORY AGENT | 2011 |
|
RU2458126C1 |
| ANTI-INFLAMMATORY AGENT | 2017 |
|
RU2654709C1 |
| USE OF METHYL 5-(4-BROMOBENZOYL)-4-METHOXY-6-(4-FLUOROPHENYL)-2-OXOHEXAHYDROPYRIMIDINE-4-CARBOXYLATE AS AGENT WITH ANTI-INFLAMMATORY ACTIVITY | 2023 |
|
RU2811248C1 |
| 1-HEXADECYL-4,6-DIMETHYL-2-OXONICOTINAMIDE EXHIBITING ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY | 2008 |
|
RU2396258C2 |
